Showing results (81-90 of 185) with videos related to

Sort By:
Pageof 19
Clinical and Translational Science|November 18, 2021
Physicochemical properties determining drug detection in skinWout Bittremieux, Rohit S Advani, Alan K Jarmusch, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 1, 2022
Time to First Subsequent Salvage Therapy in Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia Treated With Inotuzumab Ozogamicin in the Phase III INO-VATE TrialMatthias Stelljes, Anjali S Advani, Daniel J DeAngelo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 17, 1999
Essential drugs for cancer therapy: a World Health Organization consultationK Sikora, S Advani, V Koroltchouk, et al.
Leukemia Research|January 1, 1988
Characterisation of blast cells during blastic phase of chronic myeloid leukaemia by immunophenotyping--experience in 60 patientsT Saikia, S Advani, A Dasgupta, et al.
The Lancet. Oncology|March 5, 2013
Two dosing regimens of tosedostat in elderly patients with relapsed or refractory acute myeloid leukaemia (OPAL): a randomised open-label phase 2 studyJorge Cortes, Eric Feldman, Karen Yee, et al.
Leukemia & Lymphoma|October 1, 1995
Immunophenotype and ultrastructural studies in blast crisis of chronic myeloid leukemiaC Nair, H Chopra, S Shinde, et al.
Clinical Endocrinology|October 26, 2017
Double trouble: Co-occurrence of testosterone deficiency and body fatness associated with all-cause mortality in US menD S Lopez, X Qiu, S Advani, et al.
The Journal of Clinical Investigation|June 1, 1991
The spectrum of molecular alterations in the evolution of chronic myelocytic leukemiaH Ahuja, M Bar-Eli, Z Arlin, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 17, 2013
Ribosomal S6 kinase and AKT phosphorylation as pharmacodynamic biomarkers in patients with myelodysplastic syndrome treated with RAD001Anjali S Advani, Reda Z Mahfouz, Jaroslaw Maciejewski, et al.
Blood|October 2, 2008
Time from diagnosis to treatment initiation predicts survival in younger, but not older, acute myeloid leukemia patientsMikkael A Sekeres, Paul Elson, Matt E Kalaycio, et al.
Pageof 19